DISTRIBUTION OF INTRAPERITONEALLY INJECTED MICROSPHERES LABELED WITH THE ALPHA-EMITTER ASTATINE (AT-211) COMPARED WITH PHOSPHORUS (P-32) AND YTTRIUM (Y-90) COLLOIDS IN MICE

被引:20
作者
VERGOTE, I
LARSEN, RH
DEVOS, L
WINDEREN, M
ELLINGSEN, T
BJORGUM, J
HOFF, P
AAS, M
TROPE, C
NUSTAD, K
机构
[1] NORWEGIAN RADIUM HOSP,DEPT NUCL MED,OSLO 3,NORWAY
[2] NORWEGIAN RADIUM HOSP,CENT LAB,OSLO 3,NORWAY
[3] UNIV OSLO,DEPT NUCL MED,OSLO 3,NORWAY
[4] UNIV TRONDHEIM,SINTEF,TRONDHEIM,NORWAY
关键词
D O I
10.1016/0090-8258(92)90140-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The α-emitter 211At was bound to polymer microspheres with a diameter of 1.8 μm. The distributions in mice of intraperitoneally injected 211At microspheres, 90Y silicate colloid, and 32P chromic phosphate colloid were compared. The microspheres with 211At spread rapidly in the peritoneal cavity and remained mainly on the intraperitoneal surfaces. Intraperitoneal injection of 90Y colloid resulted in high levels in intraperitoneal fat and the diaphragm, but 1 day after injection 8.5% of the injected dose per gram was found in blood and after 6 days 2.5% was observed in bone. The highest accumulation of 32P was found in liver and spleen. The injection of additional nonradioactive chromic phosphate colloid resulted in an even higher accumulation of 32P in spleen and liver. The same phenomenon was not observed with 211At microspheres. It is suggested that it is not only the particle size which is important in the distribution of intraperitoneally injected colloid, but the amount of colloid, the type of colloid, the addition or presence of other substances such as ascites, and the animal species might also influence the distribution. In conclusion, the intraperitoneal distribution of 211At-labeled microspheres in mice was favorable compared with 90Y and 32P colloid. These data must be viewed cautiously since the distribution might be different in other animal species or humans. © 1992.
引用
收藏
页码:358 / 365
页数:8
相关论文
共 33 条
[1]   UPTAKE OF COLLOIDAL CHROMIC RADIOPHOSPHATE (P32) BY BONE AND GONADS [J].
ANGHILERI, LJ .
RADIOLOGY, 1965, 85 (05) :938-+
[2]   EFFECT OF OXYGEN ON IMPAIRMENT OF PROLIFERATIVE CAPACITY OF HUMAN CELLS IN CULTURE BY IONIZING RADIATIONS OF DIFFERENT LET [J].
BARENDSE.GW ;
KOOT, CJ ;
VANKERSE.GR ;
BEWLEY, DK ;
FIELD, SB ;
PARNELL, CJ .
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY AND RELATED STUDIES IN PHYSICS CHEMISTRY AND MEDICINE, 1966, 10 (04) :317-&
[3]   AT-211 RADIOCOLLOID THERAPY - FURTHER OBSERVATIONS AND COMPARISON WITH RADIOCOLLOIDS OF P-32, DY-165, AND Y-90 [J].
BLOOMER, WD ;
MCLAUGHLIN, WH ;
LAMBRECHT, RM ;
ATCHER, RW ;
MIRZADEH, S ;
MADARA, JL ;
MILIUS, RA ;
ZALUTSKY, MR ;
ADELSTEIN, SJ ;
WOLF, AP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (03) :341-348
[4]   WHOLE-BODY DISTRIBUTION OF RADIOACTIVITY AFTER INTRAPERITONEAL ADMINISTRATION OF P-32 COLLOIDS [J].
BOYE, E ;
LINDEGAARD, MW ;
PAUS, E ;
SKRETTING, A ;
DAVY, M ;
JAKOBSEN, E .
BRITISH JOURNAL OF RADIOLOGY, 1984, 57 (677) :395-402
[5]   TOXICITY OF ASTATINE-211 IN THE MOUSE [J].
COBB, LM ;
HARRISON, A ;
BUTLER, SA .
HUMAN TOXICOLOGY, 1988, 7 (06) :529-534
[6]  
COOPER JAD, 1953, J LAB CLIN MED, V42, P867
[7]   P-32 SCANS FOR INTRACAVITARY DISTRIBUTION STUDIES [J].
COVINGTON, EE ;
HILARIS, BS .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1973, 118 (04) :895-899
[8]   RADIOACTIVE CHROMIC PHOSPHATE SUSPENSION - STUDIES ON DISTRIBUTION, DOSE ABSORPTION, AND EFFECTIVE THERAPEUTIC RADIATION IN PHANTOMS, DOGS, AND PATIENTS [J].
CURRIE, JL ;
BAGNE, F ;
HARRIS, C ;
SULLIVAN, DL ;
SURWIT, EA ;
WILKINSON, RH ;
CREASMAN, WT .
GYNECOLOGIC ONCOLOGY, 1981, 12 (02) :193-218
[9]  
DOBSON E L, 1952, Acta Med Scand Suppl, V273, P1
[10]   DOSIMETRY IN USE OF COLLOIDAL ISOTOPES [J].
FLEAY, RF .
AUSTRALASIAN RADIOLOGY, 1971, 15 (04) :388-&